Generating functional antibodies specific for membrane spanning proteins in their native conformation is very challenging. The advantage of in-solution, cell based assays over ELISA is the study of antibody-antigen interaction in their native environment: the cell surface.
This webinar will overview:
- The use of the iQue Screener platform in various stages of antibody discovery campaigns, from stable target expressing cell line selection, to high throughput hybridoma screening, and finally to functional antibody lead characterization
- How ModiQuest Research maximized their chances of finding therapeutic leads by implementing the iQue Screener platform
The webinar will be hosted by Xtalks.
- Andrea Gorlani, Ph.D., Scientist, ModiQuest Research
- Thomas Duensing, Ph.D., Chief Technology Officer, IntelliCyt Corporation